Identification of asthma phenotypes using cluster analysis in the severe asthma research program

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 4, 2010, Pages 315-323

  Moore, Wendy C ^a,b   Meyers, Deborah A ^a,b   Wenzel, Sally E ^b   Teague, W Gerald ^b   Li, Huashi ^a   Li, Xingnan ^a   D'Agostino Jr , Ralph ^a   Castro, Mario ^b   Curran Everett, Douglas ^b   Fitzpatrick, Anne M ^b   Gaston, Benjamin ^b   Jarjour, Nizar N ^b   Sorkness, Ronald ^b   Calhoun, William J ^b   Chung, Kian Fan ^b   Comhair, Suzy A A ^b   Dweik, Raed A ^b   Israel, Elliot ^b   Peters, Stephen P ^a,b   Busse, William W ^b   Erzurum, Serpil C ^b   Bleecker, Eugene R ^a,b   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Severe Asthma Research Program   (United States)

Author keywords

Asthma phenotype; Cluster analysis; Definition; Severe asthma

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OMALIZUMAB; SALBUTAMOL; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ARTICLE; CHILD; CLUSTER ANALYSIS; DISEASE EXACERBATION; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; BRONCHODILATOR AGENTS; CHILD; CLUSTER ANALYSIS; COHORT STUDIES; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RESPIRATORY FUNCTION TESTS; SEX FACTORS; YOUNG ADULT;

EID: 76149146032     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200906-0896OC     Document Type: Article

References (45)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (GINA). National Institutes of Health; National Heart, Lung, and Blood Institute [accessed June 8, 2009; updated 2008]. Available at http://www.ginasthma.org)
2. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE for the TENOR Study Group. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 2005;116:990-995.
3. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-813.
4. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218-224.
5. Kiley J, Smith R, Noel P. Asthma phenotypes. Curr Opin Pulm Med 2007;13:19-23.
6. Wenzel SE. Severe asthma in adults. Am J Respir Crit Care Med 2005; 172:149-160.
7. Busse WW, Banks-Schlegel S, Wenzel SE. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000;106:1033-1042.
8. Moore WC, Peters SP. Severe asthma: an overview. J Allergy Clin Immunol 2006;117:487-494.
9. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000;162:2341-2351.
10. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. for the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405-413.
11. Moore WC, Meyers DA, Li H, D'Agostino R, Peters SP, Bleecker ER for the NHLBI Severe Asthma Research Program (SARP). Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2009;179: A2522.
12. Comhair SA, Ricci KS, Arroliga M, Lara AR, Dweik RA, Song W, Hazen SL, Bleecker ER, Busse WW, Chung KF, et al. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 2005;172:306-313.
13. Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG for the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. Features of severe asthma in school age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006;118:1218-1225.
14. Wenzel SE, Balzar S, Ampleford EJ, Hawkins GA, Busse WW, Calhoun WJ, Castro M, Chung KF, Erzurum S, Gaston B, et al. Il-4Rα mutations are associated with asthma exacerbations, airway obstruction, tissue mast cells/IgE expression and racial background. Am J Respir Crit Care Med 2007;175:570-576.
15. Lara AR, Khatri SB, Wang Z, Comhair SA, Xu W, Dweik RA, Bodine M, Levison BS, Hammel J, Bleecker ER, et al. for the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008;178:673-681.
16. Sorkness RL, Bleecker ER, Busse W, Calhoun WJ, Castor M, Chung KF, Curran-Everett D, Erzurum SC, Gaston BM, Israel E, et al. for the National Heart, Lung, Blood Institute Severe Asthma Research Program. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008;104:394-403.
17. Brasier AR, Victor S, Boetticher GD, Ju H, Lee C, Bleecker ER, Castro M, Busse WW, Calhoun WJ. Molecular phenotyping of severe asthma suing pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 2008;121:30-37.
18. Aysola RS, Hoffman EA, Gierada D, Wenzel S, Cook-Granroth J, Tarsi J, Zheng J, Schechtman KB, Ramkumar TP, Cochran R, et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest 2008;134:1183-1191.
19. Busacker A, Newell JD Jr, Keefe T, Hoffman EA, Granroth JC, Castro M, Fain S, Wenzel S. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest 2009;135:48-56.
20. Breiman L, Friedman J, Stone C, Olshen RA. Classification and regression trees. New York: Chapman & Hall; 1984.
21. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF, Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use and lung function. Am J Respir Crit Care Med 2004;170:426-432.
22. Gelfand EW. Pediatric asthma: a different disease. Proc Am Thorac Soc 2009;6:278-282.
23. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836-844.
24. Panhuysen CIM, Vonk JM, Koeter GH, Schouten JP, Bleecker ER, Postma DS. Adult patients may outgrow their asthma: a 25 year follow-up study. Am J Respir Crit Care Med 1997;155:1267-1272.
25. Jenkins HA, Cherniack R, Szefler SJ, Covar R, Gelfand EW, Spahn JD. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003;124:1318-1324.
26. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001;164:744-748.
27. Miranda C, Busacker A, Balzar S, Trudeau J,Wenzel SE. Distinguishing severe asthma phenotypes: role of age of onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113:101-108.
28. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau J, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008.
29. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360:1715-1721.
30. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-2173.
31. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007;176:231-237.
32. Wedes S, Khatri S, Zhang R, W Wu, Comhair SAA, Wenzel SE, Teague WG, Israel E, Erzurum SC, Hazen SL. Noninvasive markers of airway inflammation in asthma. Clin Translational Sci 2009;2:112-117.
33. Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, Weiss ST. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001;107: 61-67.
34. Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004;24:122-128.
35. Beuther DA, Sutherland ER. Overweight, obesity and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007;175:661-666.
36. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008;121:1087-1093.
37. Mosen DM, Schatz M, Magid DJ, Camargo CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008;122:507-511.
38. Sutherland TJT, Cowan JO, Taylor DR. Dynamic hyperinflation with bronchoconstriction: differences between obese and nonobese women with asthma. Am J Respir Crit Care Med 2008;177:970-975.
39. Calverley P, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, for the TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789.
40. Sutherland TJT, Cowan JO, Young S, Goulding A, Grant AM, Williamson A, Brassett K, Herbison GP, Taylor DR. The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med 2008;178: 469-475.
41. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999;103: 232-237.
42. Pillai SG, Tang Y, van den Oord E, Klotsman M, Barnes K, Carlsen K, Gerritsen J, Lenney W, Silverman M, Sly P, et al. Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes. Clin Exp Allergy 2008;38: 421-429.
43. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (In press)
44. Panhuysen CIM, Bleecker ER, Koeter GH, Meyers DA, Postma DS. Characterization of obstructive airways disease in family members of probands with asthma: an algorithm for the diagnosis of asthma. Am J Respir Crit Care Med 1998;157:1734-1742.
45. Celedon JC, Silverman EK, Weiss ST, Wand B, Fang Z, Xu X. Application of an algorithm for the diagnosis of asthma in Chinese families. Am J Respir Crit Care Med 2000;162:1679-1684.